Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Daiichi Sankyo
McKinsey
Accenture
Farmers Insurance
Express Scripts
QuintilesIMS
Covington
Boehringer Ingelheim

Generated: October 22, 2018

DrugPatentWatch Database Preview

Perrigo Israel Company Profile

« Back to Dashboard

What is the competitive landscape for PERRIGO ISRAEL, and what generic and branded alternatives to PERRIGO ISRAEL drugs are available?

PERRIGO ISRAEL has twenty-nine approved drugs.



Summary for Perrigo Israel
US Patents:0
Tradenames:20
Ingredients:20
NDAs:29
Patent Litigation for Perrigo Israel: See patent lawsuits for Perrigo Israel

Drugs and US Patents for Perrigo Israel

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo Israel DESOXIMETASONE desoximetasone SPRAY;TOPICAL 206441-001 Jan 20, 2017 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Perrigo Israel TRIAMCINOLONE ACETONIDE triamcinolone acetonide SPRAY, METERED;NASAL 078104-001 Jul 30, 2009 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Perrigo Israel TESTOSTERONE testosterone GEL, METERED;TRANSDERMAL 204268-001 Aug 4, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for PERRIGO ISRAEL drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Vaginal Cream 2% ➤ Subscribe 2009-12-23
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Dow
Teva
Deloitte
Citi
Fish and Richardson
Fuji
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.